RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Evoke Pharma Stock

Evoke Pharma Liabilities 2024

Evoke Pharma Liabilities

9.65 M USD

Ticker

EVOK

ISIN

US30049G1040

WKN

A1W6DP

In 2024, Evoke Pharma's total liabilities amounted to 9.65 M USD, a 24.17% difference from the 7.77 M USD total liabilities in the previous year.

Evoke Pharma Aktienanalyse

What does Evoke Pharma do?

Evoke Pharma Inc. is a pharmaceutical company that was founded in 2007 and is based in San Diego, California. It focuses on developing innovative drugs for gastrointestinal disorders. Evoke Pharma ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Evoke Pharma's Liabilities

Evoke Pharma's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Evoke Pharma's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Evoke Pharma's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Evoke Pharma's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Evoke Pharma’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Evoke Pharma stock

What is the level of liabilities of Evoke Pharma this year?

Evoke Pharma has a debt balance of 9.65 M USD this year.

What were the liabilities of Evoke Pharma compared to the previous year?

The liabilities of Evoke Pharma have increased by 24.17% increased compared to the previous year.

What are the consequences of high debt for investors of Evoke Pharma?

High liabilities can pose a risk for investors of Evoke Pharma, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Evoke Pharma?

Low liabilities mean that Evoke Pharma has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Evoke Pharma affect the company?

An increase in liabilities of Evoke Pharma can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Evoke Pharma affect the company?

A decrease in the liabilities of Evoke Pharma can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Evoke Pharma?

Some factors that can influence the liabilities of Evoke Pharma include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Evoke Pharma so important for investors?

The liabilities of Evoke Pharma are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Evoke Pharma take to modify the liabilities?

To change its liabilities, Evoke Pharma can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Evoke Pharma pay?

Over the past 12 months, Evoke Pharma paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Evoke Pharma is expected to pay a dividend of 0 USD.

What is the dividend yield of Evoke Pharma?

The current dividend yield of Evoke Pharma is .

When does Evoke Pharma pay dividends?

Evoke Pharma pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Evoke Pharma?

Evoke Pharma paid dividends every year for the past 0 years.

What is the dividend of Evoke Pharma?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Evoke Pharma located?

Evoke Pharma is assigned to the 'Health' sector.

Wann musste ich die Aktien von Evoke Pharma kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Evoke Pharma from 12/20/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/20/2024.

When did Evoke Pharma pay the last dividend?

The last dividend was paid out on 12/20/2024.

What was the dividend of Evoke Pharma in the year 2023?

In the year 2023, Evoke Pharma distributed 0 USD as dividends.

In which currency does Evoke Pharma pay out the dividend?

The dividends of Evoke Pharma are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Evoke Pharma stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Evoke Pharma

Our stock analysis for Evoke Pharma Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Evoke Pharma Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.